BR112023018942A2 - Formulações estáveis de indocianina verde - Google Patents
Formulações estáveis de indocianina verdeInfo
- Publication number
- BR112023018942A2 BR112023018942A2 BR112023018942A BR112023018942A BR112023018942A2 BR 112023018942 A2 BR112023018942 A2 BR 112023018942A2 BR 112023018942 A BR112023018942 A BR 112023018942A BR 112023018942 A BR112023018942 A BR 112023018942A BR 112023018942 A2 BR112023018942 A2 BR 112023018942A2
- Authority
- BR
- Brazil
- Prior art keywords
- indocyanine green
- stable
- formulations
- green formulations
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
- A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21305323 | 2021-03-17 | ||
| PCT/EP2022/056445 WO2022194733A2 (en) | 2021-03-17 | 2022-03-14 | Stable formulations of indocyanine green |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023018942A2 true BR112023018942A2 (pt) | 2023-10-10 |
Family
ID=75302475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023018942A BR112023018942A2 (pt) | 2021-03-17 | 2022-03-14 | Formulações estáveis de indocianina verde |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240165275A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4308081A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7842776B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN116997325B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023018942A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022194733A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119215199B (zh) * | 2024-10-12 | 2025-12-09 | 石家庄四药有限公司 | 一种注射用吲哚菁绿的冻干工艺 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08509260A (ja) * | 1993-04-20 | 1996-10-01 | マリンクロット・メディカル・インコーポレイテッド | 電圧感受性染料の安定化 |
| FR2710060B1 (fr) | 1993-09-17 | 1995-11-17 | Rech Biolog Et | Procédé de préparation de benz[e]indoles substitués de pureté élevée et leurs sels alcalins. |
| GB9712524D0 (en) | 1997-06-16 | 1997-08-20 | Nycomed Imaging As | Method |
| US6944493B2 (en) | 1999-09-10 | 2005-09-13 | Akora, Inc. | Indocyanine green (ICG) compositions and related methods of use |
| US8337809B2 (en) * | 2006-09-11 | 2012-12-25 | William Marsh Rice University | Charge-assembled capsules for phototherapy |
| DE102007030403A1 (de) | 2007-06-29 | 2009-01-08 | Universität Bielefeld | Verfahren zur Verbesserung der Photostabilität von Fluoreszenzfarbstoffen |
| JP5257971B2 (ja) | 2007-10-25 | 2013-08-07 | 国立大学法人 千葉大学 | 胚性幹細胞から肝芽細胞を得る方法 |
| CN103301482B (zh) | 2013-06-27 | 2014-12-17 | 深圳先进技术研究院 | 两亲性三嵌段聚多肽载icg胶束及其制备方法 |
| JP2015040185A (ja) | 2013-08-21 | 2015-03-02 | キヤノン株式会社 | 造影用組成物 |
| JP6623479B2 (ja) | 2015-02-08 | 2019-12-25 | トンリ・バイオメディカル・カンパニー・リミテッド | 脂質ナノ粒子及びその使用 |
| CA3021809A1 (en) | 2015-05-11 | 2016-11-17 | Dicronis Sagl | Compositions for circulatory system visualization |
| DK3383436T3 (da) | 2015-12-01 | 2023-11-20 | Dishman Carbogen Amcis Ltd | Forbedret fremgangsmåde til fremstilling af indocyaningrønt |
| US20190337896A1 (en) | 2018-05-02 | 2019-11-07 | Biophore India Pharmaceuticals Pvt. Ltd. | PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN) |
| WO2020240514A1 (en) * | 2019-05-30 | 2020-12-03 | Leiutis Pharmaceuticals Pvt, Ltd. | Stable formulations of indocyanine green |
| CN111514125B (zh) * | 2020-05-26 | 2021-03-23 | 中山万汉制药有限公司 | 含有喹诺酮类化合物与依地酸类化合物的组合物 |
-
2022
- 2022-03-14 US US18/549,373 patent/US20240165275A1/en active Pending
- 2022-03-14 WO PCT/EP2022/056445 patent/WO2022194733A2/en not_active Ceased
- 2022-03-14 EP EP22712419.5A patent/EP4308081A2/en active Pending
- 2022-03-14 CN CN202280021996.7A patent/CN116997325B/zh active Active
- 2022-03-14 BR BR112023018942A patent/BR112023018942A2/pt unknown
- 2022-03-14 JP JP2023557322A patent/JP7842776B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN116997325A (zh) | 2023-11-03 |
| EP4308081A2 (en) | 2024-01-24 |
| US20240165275A1 (en) | 2024-05-23 |
| JP7842776B2 (ja) | 2026-04-08 |
| WO2022194733A2 (en) | 2022-09-22 |
| WO2022194733A3 (en) | 2022-11-10 |
| JP2024510302A (ja) | 2024-03-06 |
| CN116997325B (zh) | 2025-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR092470A1 (es) | Formulaciones acuosas estables de adalimumab | |
| BR0107811A (pt) | Composição herbicida | |
| BR112012021873B8 (pt) | composição de matéria, artigo de manufatura, métodos para preparar uma composição, para aumentar a estabilidade de uma proteína em solução aquosa livre de polissorbato e para prevenir ou reduzir a agregação de uma proteína em solução aquosa livre de polissorbato | |
| HRP20161771T4 (hr) | Formulacije bendamustina | |
| CL2020002252A1 (es) | Formulación oftálmica. | |
| AR094012A1 (es) | Composiciones estables con peroxido para el cuidado oral | |
| AR036248A1 (es) | Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica | |
| AR037755A1 (es) | Composiciones acuosas con contenido de metronidazol | |
| EA200970377A1 (ru) | Композиции фенилалкиламинокарбамата | |
| MX373040B (es) | Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservador. | |
| EA202092926A2 (ru) | Лиофилизированные составы, содержащие фактор ix | |
| CY1122084T1 (el) | Συνθεσεις που περιλαμβανουν αμλοδιπινη και μπισοπρολολη | |
| CO6180423A2 (es) | Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona | |
| JP2017514924A5 (cg-RX-API-DMAC7.html) | ||
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| MX2022000623A (es) | Composiciones y kits para una suspension de omeprazol. | |
| NO20091492L (no) | Fenylalkylkarbamatsammensetninger | |
| UY39094A (es) | Composición farmacéutica que comprende compuesto derivado de bencimidazol | |
| MX2021014310A (es) | Formulaciones de terlipressina. | |
| BR112012030415A2 (pt) | composições pesticidas | |
| JOP20190156B1 (ar) | أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1 | |
| EA200702593A1 (ru) | Высококонцентрированные композиции, применимые для борьбы с экто- и эндопаразитами | |
| CO2021014255A2 (es) | Composiciones antifúngicas | |
| BR112019006292A2 (pt) | composições e métodos | |
| WO2022194733A3 (en) | Stable formulations of indocyanine green |